Life Sciences VistaGen Reports Positive New Data From Second Preclinical Study of AV-101 in Combination With… AIT News Desk Sep 4, 2020 New Results Complement Earlier Positive Preclinical Data Demonstrating Increase in Brain Concentration Effects VistaGen Therapeutics, a…